Michael Purvis
About Michael Purvis
Executive Vice President, General Counsel & Corporate Strategy at Veru Inc.
Michael J. Purvis is currently serving as the Executive Vice President, General Counsel, and Corporate Strategy at Veru Inc. He joined the company in March 2021. With extensive experience in the legal sector, he brings robust leadership and strategic planning skills to Veru. His role involves overseeing the legal framework and helping craft corporate strategies to foster the company's growth and stability.
Previous Experience at Incyte Corp.
Before joining Veru, Michael J. Purvis was Vice President, Assistant General Counsel, and Assistant Secretary at Incyte Corp. from February 2015 to February 2021. During his tenure, he played a crucial role in building and leading the legal team as Incyte evolved into an S&P 500 company. His efforts contributed significantly to the company's focus on oncology, inflammation and autoimmunity, and dermatology.
Legal Career at Auxilium Pharmaceuticals
Michael J. Purvis held the position of Senior Associate General Counsel & Assistant Secretary at Auxilium Pharmaceuticals. In this role, he managed disclosure and securities law matters, strategic transactions, and corporate affairs. His leadership was instrumental until Auxilium's successful acquisition by Endo Pharmaceuticals.
Early Career and Education
Michael J. Purvis began his legal career in 1997 at Sullivan & Cromwell in New York City, later joining Dechert LLP in Philadelphia in 2000. He served as Senior Counsel at Susquehanna International Group from 2003 to 2009, supporting the healthcare research group and aiding in the establishment of investment banking and private equity departments. He also held a legal role at West Pharmaceutical Services from 2009 to 2010.
Academic Background
Michael J. Purvis earned his J.D., magna cum laude, from Boston University School of Law. He also received his B.A., magna cum laude, in Latin and Classical Humanities from The Catholic University of America in Washington, D.C.